50AM 50mg*10vials

5-Amino-1MQ 50AM 50mg*10vials

5-Amino-1MQ is a novel small molecule research compound designed to inhibit NNMT (Nicotinamide N-methyltransferase), an enzyme that consumes NAD+ and regulates cellular metabolism. It represents the highest-concentration research compound in the 5-Amino-1MQ product line, designed for metabolic and longevity studies.

The 50mg single-vial specification delivers the maximum active ingredient load available, ten times the content of the standard 5mg. This premium flagship formulation is engineered for ultra-long-term large animal models, extreme high-dose NAD+ pathway efficacy validation, and the largest-scale multi-group parallel research projects. The exceptionally high concentration per vial eliminates repeated dilution steps across very long experimental timelines, reducing data deviation and sample contamination risk.

Through its NNMT inhibitory action, 5-Amino-1MQ supports comprehensive research into cellular NAD+ level maintenance, fat metabolism regulation, and energy production. It is designed to study how blocking NNMT can preserve NAD+ availability, supporting metabolic health, fat reduction, and cellular energy balance.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Every batch undergoes rigorous purity testing, with a complete certificate of analysis provided.

10 vials per pack, designed for top-tier professional research institutions and large-scale global wholesale procurement.